Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-24 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28 |
filingDate |
1992-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1995-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9dc5348efb6f9885d9f9a5beaaad30b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb7b67922ee7820c19e6bb66a9dce02f |
publicationDate |
1995-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5433954-A |
titleOfInvention |
Method and composition for treating psoriasis, seborrheic dermatitis and eczema |
abstract |
Psoriasis, seborrheic dermatitis and eczema are treated by oral administration of inorganic nickel compound(s), with or without inorganic bromide(s). In an especially preferred embodiment, the nickel compound used to treat these diseases is NiBr 2 . |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5681593-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6844014-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5716646-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6613800-B1 |
priorityDate |
1990-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |